These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 28849183)

  • 21. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
    Qi H; Wang Y
    Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
    Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
    Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
    Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
    BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy.
    Zhu Y; Yang J; Li Y; Xu J; Fang Z
    Med Oncol; 2023 Mar; 40(5):130. PubMed ID: 36971873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
    Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
    Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship Between the Expression of Human Matricellular Protein 3 and the Pathological Features, Drug Resistance, and Prognosis of Gastric Cancer Based on Immunohistochemical Method].
    Li J; Yu D; Chen S; Xie B; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jul; 55(4):893-901. PubMed ID: 39170027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel evidence for m
    Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A
    Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner.
    Yin Z; Guo X; Liang X; Wang Z
    Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinculin promotes gastric cancer proliferation and migration and predicts poor prognosis in patients with gastric cancer.
    Zhang M; Liu P; Xu F; He Y; Xie X; Jiang X
    J Cell Biochem; 2019 Aug; 120(8):14107-14115. PubMed ID: 30989694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
    Yuan X; Zhang T; Zheng X; Zhang Y; Feng T; Liu P; Sun Z; Qin S; Liu X; Zhang L; Song J; Liu Y
    Oncol Rep; 2017 Sep; 38(3):1733-1741. PubMed ID: 28677734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
    Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
    Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression of lncRNA NBAT-1 promotes gastric cancer development and is associated with poor prognosis.
    Gao Y; Chen J
    J BUON; 2019; 24(2):656-662. PubMed ID: 31128020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway.
    Zeng X; Lu Y; Zeng T; Liu W; Huang W; Yu T; Tang X; Huang P; Li B; Wei H
    Commun Biol; 2024 Jul; 7(1):800. PubMed ID: 38956367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer.
    Du DX; Lian DB; Amin BH; Yan W
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
    Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
    Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
    [No Abstract]   [Full Text] [Related]  

  • 40. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.